期刊档案 · PERIPHERAL VASCULAR DISEASE
Annals of Vascular Diseases
ISSN 1881-641X · eISSN 1881-6428 · The Editorial Committee of Annals of Vascular Diseases · Japan
Annals of Vascular Diseases 中科院 医学 4区（2025 年升级版），完全开放获取，APC 约 226 美元，近 24 个月 104 篇文章投稿到接收中位 98 天，2025 年发文 62 篇，ESCI 收录。
研究范围
研究范围与定位
Annals of Vascular Diseases 由 The Editorial Committee of Annals of Vascular Diseases 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Aortic aneurysm repair treatments、Aortic Disease and Treatment Approaches、Vascular Procedures and Complications 等主题的论文，这 3 个主题约占 37.9%，主导子领域为 Surgery、Pulmonary and Respiratory Medicine。（根据 OpenAlex 主题统计与中科院分区数据生成）
Annals of Vascular Diseases (AVD) publishes Open Access, peer-reviewed original research articles, reviews, case reports, clinical trials, and methods in vascular research and allied fields. Topics include vascular and endovascular surgery, vascular medicine, peripheral vascular disease, and venous and lymphatic disease. Epidemiology, exercise, genetics, translational biology, health services, and transplantation related to vascular science are also considered. The journal encourages authors anywhere in the world to submit original and important work on clinical and other investigations relating to vascular diseases and angiology. The editors are especially interested in articles that provide clues to the underlying causes of disease or lead to effective treatments. AVD also welcomes articles that provide conceptual breakthroughs. As the official journal of the Japanese College of Angiology, the Japanese Society for Vascular Surgery, and the Japanese Society of Phlebology, the journal publishes peer-reviewed annual reports and selected papers presented at the annual society meetings, as well as original articles from members and non-members.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：PERIPHERAL VASCULAR DISEASE
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Aortic aneurysm repair treatmentsMedicine16.7%
- Aortic Disease and Treatment ApproachesMedicine12%
- Vascular Procedures and ComplicationsMedicine9.2%
- Peripheral Artery Disease ManagementMedicine8.3%
- Venous Thromboembolism Diagnosis and ManagementMedicine6.5%
- Infectious Aortic and Vascular ConditionsMedicine6.3%
- Diagnosis and Treatment of Venous DiseasesMedicine5.2%
- Cardiac, Anesthesia and Surgical OutcomesMedicine4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 外周血管病PERIPHERAL VASCULAR DISEASE | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 外周血管病PERIPHERAL VASCULAR DISEASE | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
PMC出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 38OpenAlex ·
- i10-index
- 322OpenAlex ·
- 两年平均被引
- 0.78OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 99.45%LetPub ·
发文规模
- 年文章数
- 58LetPub ·
- 年发文量（出版商公布）
- 1出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 1,418 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 87 | 87 | 11 |
| 2025 | 62 | 62 | 63 |
| 2024 | 75 | 75 | 101 |
| 2023 | 59 | 59 | 134 |
| 2022 | 64 | 64 | 205 |
| 2021 | 79 | 79 | 333 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
98 天投稿到接收中位数 · P25–P75 70 天 – 137 天
- 接收到上线
- 中位数 23 天（104 篇）
- 投稿到上线
- 中位数 121 天
- 样本
- 104 篇有投稿与接收日期的文章（窗口内共 175 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 23 WeeksLetPub ·
- 评审方式
- 匿名同行评审LetPub
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取OpenAlex
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | JPY 30,000 | — | — | |
| LetPub | JPY 30,000 | 无 | — | |
| 出版商官网 | 有，金额未公布 | — | — |
其他费用与减免（作者指南）
- 投稿费
- 无投稿费
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 200 词
- 正文篇幅
- ≤ 4,800 词
- 参考文献格式
- Vancouver 格式
- 推荐审稿人
- 可选
- 投稿信（Cover letter）
- 可选
接收的文章类型11 种，含篇幅限制
- case reportThe journal welcomes five manuscript types, all of which are subject to peer review. Original Articles Original Articles are full and comprehensive reports desc…正文 ≤ 2,400 词
- case reportsCase Reports are high-quality clinical case reports in all aspects of vascular medicine. Case Reports must be valuable and educational, and must present unique …未说明篇幅
- clinical trialsClinical Trials are brief descriptions of important clinical trials, with an Introduction, main text, Discussion and Conclusion. They should be no more than 240…未说明篇幅
- editoriales 3 printed pages / 2,400 words 3 10 3 Editorial 2 printed pages / 1,600 words Not applicable 10 3 The final page count is determined only正文 ≤ 1,600 词
- new methods and techniquesNew Methods and Techniques are innovative, brief articles that aim to educate readers about a particular clinical subject – for example, describing the efficien…未说明篇幅
- original articleThe journal welcomes five manuscript types, all of which are subject to peer review. Original Articles Original Articles are full and comprehensive reports desc…正文 ≤ 4,800 词
- original articlesOriginal Articles are full and comprehensive reports describing all types of original research and clinical studies. They should be no more than 4,800 words (or…未说明篇幅
- original researchThe journal welcomes five manuscript types, all of which are subject to peer review. Original Articles Original Articles are full and comprehensive reports desc…未说明篇幅
- reviewThe journal welcomes five manuscript types, all of which are subject to peer review. Original Articles Original Articles are full and comprehensive reports desc…未说明篇幅
- review articleThe journal welcomes five manuscript types, all of which are subject to peer review. Original Articles Original Articles are full and comprehensive reports desc…正文 ≤ 8,000 词
- review articlesReview Articles focus on topics of interest to vascular scientists and should provide comprehensive and definitive information. Review Articles provide overview…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、查重、自存档、试验注册 / 报告规范
- AI 使用 Use of Artificial Intelligence (AI) and AI-Assisted Technologies
作者必须在稿件的致谢部分披露并完整描述生成式或非生成式人工智能工具的任何使用，涵盖写作、数据分析、图像制作等各个方面。 模型中文摘要
Disclosure and Use of AI Tools: Authors must disclose and fully describe any use of generative or non-generative AI tools in the Acknowledgments section of the manuscript. This requirement applies to all aspects of the work, including but not limited to: Writing or editing all or part of the manuscript. Data collection, analysis, or interpretation. Production or modification of images, graphics, o…
原文 ↗出版商官网 ·- 作者资格 Authorship
投稿即表示所有作者已确认并同意作者名单，投稿后对作者名单的任何变动须经所有作者和编辑批准，且所有作者须符合基于ICMJE建议的标准。 模型中文摘要
Submission to the journal implies that all authors have seen and approved the author list. Changes to the author list after manuscript submission – such as the insertion or removal of author names, or a rearrangement of author order – must be approved by all authors and the editor. All authors should meet all the criteria below, which are based on ICMJE Recommendations (http://www.icmje.org). Thos…
原文 ↗出版商官网 ·- 利益冲突 COI Disclosure form
《血管疾病年鉴》是由日本血管学会等三个学会赞助的开放获取在线期刊，同时也是亚洲血管外科学会和亚洲静脉论坛的官方期刊。 模型中文摘要
Updated: September 14, 2026 Annals of Vascular Diseases (AVD) is an online Open Access journal with a continuous publication model, reporting advances in medical, surgical, and endovascular science in vascular diseases. The journal is sponsored by the three societies: the Japanese College of Angiology, the Japanese Society for Vascular Surgery, and the Japanese Society of Phlebology. AVD is also t…
原文 ↗出版商官网 ·- 数据可用性 Availability of data and materials
作者必须披露公开可用数据和材料的来源，在同行评审期间向编辑和审稿人提供完整数据集，并在发表之日之前将数据公开。 模型中文摘要
Authors must disclose the source of publicly available data and materials, such as public repositories or commercial manufacturers, by including accession numbers or company details in their manuscript, as appropriate. Authors may make their own data and materials available in Supplementary Material, or by linking from their manuscript to relevant community-recognized public databases or digital r…
原文 ↗出版商官网 ·- 许可与版权 Copyright, Open Access and Fees
所有被接受的稿件归ECAVD所有，并根据知识共享署名（CC BY）4.0国际许可协议发表，允许在注明出处的情况下自由共享和改编。 模型中文摘要
AVD is fully Open Access and uses a Creative Commons (CC) license, which allows users to use, reuse and build upon the material published in the journal without charge or, in many cases, the need to ask prior permission from the publisher or author (see https://creativecommons.org). All accepted manuscripts become the property of the ECAVD and are published under the Creative Commons CC BY (Attrib…
原文 ↗出版商官网 ·- 开放获取 Self-archiving (Green Open Access) policy
AVD鼓励原创研究论文的作者在文章发表后立即将稿件上传至机构或公共存储库（绿色开放获取）。 模型中文摘要
Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. AVD encourages authors of original research manuscripts to upload their article to an institutional or public repository immediately after publication in the journal.
原文 ↗出版商官网 ·- 同行评审 Peer Review Process
该期刊采用单盲同行评审，所有投稿首先由主编评估，符合条件的稿件由副编辑指派至少两名审稿人进行评审。 模型中文摘要
Editorial and peer review process The journal uses single-blind peer review. The editors and reviewers, by providing prompt and authoritative review, aim to optimize the quality of the published articles. All submitted manuscripts are firstly assessed by the Editor-in-Chief. With the exception for submissions that are outside the scope of the journal or do not have sufficient merit to warrant furt…
原文 ↗出版商官网 ·- 查重
期刊使用iThenticate查重软件对所有稿件进行原创性筛查。 模型中文摘要
The journal uses iThenticate plagiarism software (see https://www.ithenticate.com) to screen all manuscripts for unoriginal content.
原文 ↗出版商官网 ·- 自存档 Self-archiving (Green Open Access) policy
AVD鼓励原创研究论文的作者在文章发表后立即将稿件上传至机构或公共存储库。 模型中文摘要
Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. AVD encourages authors of original research manuscripts to upload their article to an institutional or public repository immediately after publication in the journal.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical trial registration
期刊遵循ICMJE临床试验注册政策，要求临床试验在首位患者入组时或之前在公共试验注册机构注册，且稿件须包含注册号和注册机构名称。 模型中文摘要
The journal adheres to the International Committee of Medical Journal Editors (ICMJE) policy on Clinical Trials Registration, which recommends that all clinical trials are registered in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. Manuscripts describing clinical trials must include the registration number of the trial a…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- The Editorial Committee of Annals of Vascular Diseases
- 出版国家或地区
- Japan
- 出版语言
- English
- ISSN
- 1881-641X
- 电子版 ISSN
- 1881-6428
- 学会 / 主办单位
- Asian Society for Vascular Surgery
常见问题
关于 Annals of Vascular Diseases 的常见问题
Annals of Vascular Diseases 是中科院几区期刊？
2025 年升级版分区表中，Annals of Vascular Diseases 为医学 4区，小类 外周血管病 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Annals of Vascular Diseases 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）104 篇已发表文章登记的日期，投稿到接收的中位数为 98 天（四分位 70–137 天）；投稿社区反馈的平均审稿速度为约 23 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Annals of Vascular Diseases 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 200 词；正文篇幅：≤ 4,800 词；参考文献格式：Vancouver 格式；推荐审稿人：可选；投稿信：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Annals of Vascular Diseases 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Annals of Vascular Diseases 被 ESCI、DOAJ 收录。期刊官网自述还被 PMC 收录，该清单未与各数据库逐一核对。
Annals of Vascular Diseases 是开放获取期刊吗？版面费多少？
Annals of Vascular Diseases 为完全开放获取。APC 约 226 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。